Advertisement

Topics

Oragenics Receives Approval for Phase 2 Study

18:50 EDT 17 Oct 2018 | Investing News Network

Oragenics announced Wednesday that it has been approved in Belgium to enroll patients in its Phase 2 trial for its drug AG013 for a mouth disorder, Oral Mucositis.

The post Oragenics Receives Approval for Phase 2 Study appeared first on Investing News Network.

Original Article: Oragenics Receives Approval for Phase 2 Study

NEXT ARTICLE

More From BioPortfolio on "Oragenics Receives Approval for Phase 2 Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...